Your browser doesn't support javascript.
loading
Second-Generation AUTACs for Targeted Autophagic Degradation.
Takahashi, Daiki; Ora, Taiichi; Sasaki, Shigekazu; Ishii, Naoki; Tanaka, Toshio; Matsuda, Takumi; Ikeda, Mutsuki; Moriyama, Jun; Cho, Nobuo; Nara, Hiroshi; Maezaki, Hironobu; Kamaura, Masahiro; Shimokawa, Kenichiro; Arimoto, Hirokazu.
Afiliación
  • Takahashi D; Graduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, Japan.
  • Ora T; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Sasaki S; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Ishii N; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Tanaka T; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Matsuda T; Graduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, Japan.
  • Ikeda M; Graduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, Japan.
  • Moriyama J; Graduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, Japan.
  • Cho N; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Nara H; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Maezaki H; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Kamaura M; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Shimokawa K; Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Arimoto H; Graduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, Japan.
J Med Chem ; 66(17): 12342-12372, 2023 09 14.
Article en En | MEDLINE | ID: mdl-37589438
ABSTRACT
Targeted protein degradation via the ubiquitin-proteasome system has emerged as one of the most promising drug discovery modalities. Autophagy, another intracellular degradation system, can target a wide range of nonproteinous substrates as well as proteins, but its application to targeted degradation is still in its infancy. Our previous work revealed a relationship between guanine modification of cysteine residues on intracellular proteins and selective autophagy, resulting in the first autophagy-based degraders, autophagy-targeted chimeras (AUTACs). Based on the research background, all the reported AUTACs compounds contain cysteine as a substructure. Here, we examine the importance of this substructure by conducting SAR studies and report significant improvements in the degrader's activity by replacing cysteine with other moieties. Several derivatives showed sub-µM range degrading activity, demonstrating the increased practical value of AUTACs.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autofagia / Cisteína Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autofagia / Cisteína Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Japón